Breast cancer: insights in disease and influence of drug methotrexate
- 28 May 2020
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 11 (6) , 646-664
Abstract
Methotrexate might be valuable to fight breast cancer.Keywords
Funding Information
- European Regional Development Fund (IF/00092/2014/CP1255/CT0004)
- Fundação para a Ciência e a Tecnologia (IF/00092/2014/CP1255/CT0004)
This publication has 174 references indexed in Scilit:
- Antibody Drug Conjugates as Cancer TherapeuticsAntibodies, 2013
- Redirected Antitumor Activity of Primary Human Lymphocytes Transduced With a Fully Human Anti-mesothelin Chimeric ReceptorMolecular Therapy, 2012
- Factors Noted to Affect Breast Cancer Treatment Decisions of Women Aged 80 and OlderJournal of the American Geriatrics Society, 2012
- Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody ReceptorClinical Cancer Research, 2011
- Mechanisms of Endocrine Resistance in Breast CancerAnnual Review of Medicine, 2011
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010
- Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literatureAnnals of the Rheumatic Diseases, 2009
- The Role of Combination Chemotherapy in the Treatment of Patients with Metastatic Breast CancerBreast Care, 2009
- The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology groupInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1980
- Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)New England Journal of Medicine, 1948